Skip to main content

RM53 RM53 (Sunitinib Malate 12.5 mg)

Pill with imprint RM53 RM53 is Brown, Capsule-shape and has been identified as Sunitinib Malate 12.5 mg. It is supplied by Sun Pharmaceutical Industries Inc.

Sunitinib is used in the treatment of gastrointestinal stromal tumor; renal cell carcinoma; pancreatic cancer and belongs to the drug classes multikinase inhibitors, VEGF/VEGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Sunitinib 12.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for RM53 RM53

Sunitinib Malate

RM53 RM53
12.5 mg
Prescription only
Drug Class
Multikinase inhibitors, VEGF/VEGFR inhibitors
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Sun Pharmaceutical Industries Inc.
National Drug Code (NDC)
Inactive Ingredients
croscarmellose sodium, magnesium stearate, mannitol, povidone k30, ferric oxide red, titanium dioxide, potassium hydroxide, shellac, gelatin

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.